mint furanone;mint lactone;mintlactone;3,6-dimethyl-5,6,7,7a-tetrahydro-4H-benzofuran-2-one;5,6,7,7a-tetrahydro-3,6-dimethyl-2(4H)-benzofuranone;Isomintlactone;3,6-dimethyl-5,6,7,7a-tetrahydro-4H-1-benzofuran-2-one
[EN] PREPARATION OF 3-HYDROXY-3,6-DIMETHYLHEXAHYDROBENZOFURAN-2-ONE AND DERIVATIVES THEREOF<br/>[FR] PRÉPARATION DE 3-HYDROXY-3,6-DIMÉTHYLHEXAHYDROBENZOFURAN-2-ONE ET DE DÉRIVÉS DE CELLE-CI
申请人:P2 SCIENCE INC
公开号:WO2017044957A1
公开(公告)日:2017-03-16
The present invention relates to the synthesis of intermediate compounds which can be used in the synthesis of mint lactone and related compounds, including 3,6-dimethylhexahydrobenzofuran-2-ones, isomers, and other derivatives.
[EN] FRAGRANCE AND FLAVOR MATERIALS DERIVED FROM 1-(4-METHYLCYCLOHEX-1-EN-1-YL)ETHAN-1-ONE<br/>[FR] SUBSTANCES PARFUMANTES ET AROMATIQUES DÉRIVÉES DE 1-(4-MÉTHYLCYCLOHEX-1-ÉN-1-YL) ETHAN-1-ONE
申请人:TAKASAGO INT CORPORATION USA
公开号:WO2019173776A1
公开(公告)日:2019-09-12
The present disclosure is directed to 1-(4-methyl cyclohex-1-en-1-yl)ethan-1-one derivatives having unique and desired flavor and/or fragrance characteristics, as well as the synthesis and application of the derivatives. The compounds of the present disclosure can be employed alone or incorporated as fragrance or flavor ingredients to modify or enhance already existing fragrance compositions, solvents, media, and the like.
Organic Compounds and Compositions Having the Ability to Modulate Fragrance Compositions
申请人:Schilling Boris
公开号:US20100111888A1
公开(公告)日:2010-05-06
Disclosed are compounds having the ability to modulate, namely to improve, enhance and or modify fragrance compositions due to their ability to inhibit cytochrome P450 enzymes, e.g. CYP2A13 and CYP2B6.
Organic Compounds Suitable For Modulating Fragrance Compositions
申请人:Granier Thierry
公开号:US20110200549A1
公开(公告)日:2011-08-18
Disclosed are compounds having the ability to modulate, namely to improve, enhance and/or modify fragrance compositions due to their ability to inhibit cytochrome P450 enzymes, e.g. CYP2A, e.g. 2A13 and 2A6, and CYP2B6.